Lycopene modulation of molecular targets affected by smoking exposure

P Palozza1, R Simone, A Catalano

  • 1Institute of General Pathology, Catholic University School of Medicine, Rome, Italy. p.palozza@rm.unicatt.it

Insights

Tomato lycopene, a potent antioxidant, shows promise in reducing cancer risk from smoking exposure. It combats reactive oxygen species (ROS) and counteracts smoke-induced cellular damage, offering protective effects against smoking-related diseases.

Area of Science:

  • Nutritional science
  • Biochemistry
  • Toxicology

Background:

  • Smoking exposure significantly increases cancer risk.
  • Reactive oxygen species (ROS) generated by smoke contribute to cellular damage and disease.
  • Lycopene, a carotenoid found in tomatoes, possesses antioxidant properties.

Purpose of the Study:

  • To review the protective effects of tomato lycopene against smoking-induced cancer risk.
  • To summarize the molecular mechanisms underlying lycopene's interaction with smoke exposure.
  • To present current knowledge on lycopene's role in mitigating smoke-related diseases.

Main Methods:

  • Review of experimental models investigating lycopene and smoke interactions.
  • Analysis of lycopene's effects on redox balance and cellular targets.
  • Examination of lycopene's impact on carcinogen metabolism and molecular pathways.

Main Results:

  • Lycopene decreases smoke-induced reactive oxygen species (ROS).
  • It modulates redox-sensitive cell targets, including kinases and transcription factors.
  • Lycopene counteracts smoke's effects on enzymes, cell proliferation, apoptosis, inflammation, IGF-signalling, and DNA adducts.

Conclusions:

  • Tomato lycopene demonstrates significant potential in protecting against smoking-related cancer risk.
  • Its antioxidant and anti-inflammatory properties offer a promising strategy for disease prevention.
  • Synergistic effects with other nutrients may enhance lycopene's protective actions.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...